Martin Shkreli must return $64.6 million US in profits he and his former company reaped from raising the price of the life-saving drug Daraprim, a federal judge ruled Friday while Shkreli from participating in the pharmaceutical industry for the rest of his life.
source https://www.cbc.ca/news/business/martin-shkreli-drug-industry-pharma-bro-daraprim-1.6315620?cmp=rss
No comments:
Post a Comment